AI Financial Intelligence
Professional analysis of central bank decisions

Markets

News
Forex
Stocks
Crypto
Gold
Commodities
Indices
ETFs

Analysis

Fed
ECB
COT
Economic Calendar

Learn

Service Guide
MCP Server
Oil

Company

About
Contact
Data Methodology
AI Disclosure
Pricing
Enterprise
Terms
Privacy
Security
WhatsApp

Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookiesPrivacy Policy

AI Financial Intelligence
Professional analysis of central bank decisions

Markets

News
Forex
Stocks
Crypto
Gold
Commodities
Indices
ETFs

Analysis

Fed
ECB
COT
Economic Calendar

Learn

Service Guide
MCP Server
Oil

Company

About
Contact
Data Methodology
AI Disclosure
Pricing
Enterprise
Terms
Privacy
Security
WhatsApp

Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

BreakingStocks

AstraZeneca Net Profit Hits $3.12 Billion in Q3 Driven by Oncology Sales

First Detected: Oct 30, 2026, 7:48 AM

Last Update: about 1 hour ago

1 update

Event Summary

AstraZeneca reported a net profit of $3.12 billion for the third quarter of 2026. This figure marks an increase from the $2.535 billion recorded by the company during the same period last year. The growth in profits was primarily driven by strong performance in oncology sales, highlighting an improved year-over-year financial position.

Timeline

Latest developmentabout 9 hours ago

AstraZeneca reports revenue of $16.209 billion and reaffirms 2026 outlook

Third-quarter results beat Reuters estimates for revenue and earnings per share, as the company announced targeted annual savings of $1.5 billion by 2029.

Read the full story

Key facts

AstraZeneca reported a net profit of $3.12 billion for the third quarter of 2026.
Profits rose compared to the $2.535 billion recorded by the company in the same period last year.

Price Impact

Since event start

AZN+6.94%